Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+1.46M
-
Total reported value, excl. options
-
$325M
-
Value change
-
+$13.2M
-
Put/Call ratio
-
0.77
-
Number of buys
-
39
-
Number of sells
-
-34
-
Price
-
$10.14
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2017
100 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2017.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 170M outstanding shares and own 18.83% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (6.08M shares), BlackRock Inc. (1.86M shares), ARK Investment Management LLC (1.63M shares), Vanguard Group Inc (1.55M shares), FEDERATED INVESTORS INC /PA/ (1.5M shares), Capital World Investors (1.04M shares), RENAISSANCE TECHNOLOGIES LLC (911K shares), JPMORGAN CHASE & CO (528K shares), and D. E. Shaw & Co., Inc. (380K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.